Go Pro

Vitalhub Corp. (TSE:VHI) Given Average Recommendation of "Buy" by Brokerages

Vitalhub logo with Medical background
Image from MarketBeat Media, LLC.

Key Points

  • Vitalhub Corp. has an average analyst rating of "Buy" from seven covering analysts, with an average 12-month target price of C$13.14.
  • Recent analyst updates were mixed but still positive: Raymond James and National Bank Financial both cut their price targets to C$11.00 while keeping outperform ratings.
  • Director Steve Garrington sold 10,000 shares at C$7.17 each, reducing his ownership by 16.67%; the stock last traded around C$7.10 after the company reported quarterly EPS of C$0.04.
  • MarketBeat previews the top five stocks to own by August 1st.

Vitalhub Corp. (TSE:VHI - Get Free Report) has received an average rating of "Buy" from the seven analysts that are currently covering the stock, Marketbeat reports. Six analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The average twelve-month target price among analysts that have issued ratings on the stock in the last year is C$13.14.

VHI has been the subject of several analyst reports. Raymond James Financial lowered their price objective on Vitalhub from C$15.00 to C$11.00 and set an "outperform" rating for the company in a research note on Tuesday, March 24th. National Bank Financial dropped their target price on Vitalhub from C$14.00 to C$11.00 and set an "outperform" rating for the company in a report on Wednesday, May 27th.

Read Our Latest Research Report on Vitalhub

Insider Transactions at Vitalhub

In other Vitalhub news, Director Steve Garrington sold 10,000 shares of Vitalhub stock in a transaction on Friday, June 5th. The shares were sold at an average price of C$7.17, for a total transaction of C$71,700.00. Following the completion of the transaction, the director directly owned 50,000 shares of the company's stock, valued at C$358,500. The trade was a 16.67% decrease in their ownership of the stock. 18.57% of the stock is currently owned by corporate insiders.

Vitalhub Stock Performance

Shares of TSE VHI opened at C$7.10 on Monday. The firm's 50-day moving average price is C$7.23 and its 200-day moving average price is C$7.79. The stock has a market capitalization of C$449.15 million, a price-to-earnings ratio of 59.17, a P/E/G ratio of 1.18 and a beta of 0.91. Vitalhub has a 12-month low of C$6.62 and a 12-month high of C$14.64.

Vitalhub (TSE:VHI - Get Free Report) last released its quarterly earnings results on Thursday, May 7th. The company reported C$0.04 EPS for the quarter. Vitalhub had a return on equity of 2.98% and a net margin of 6.13%.The company had revenue of C$31.91 million during the quarter. On average, equities analysts predict that Vitalhub will post 0.2296467 EPS for the current fiscal year.

About Vitalhub

(Get Free Report)

VitalHub is a leading software company dedicated to empowering health and human services providers globally. VitalHub's comprehensive product suite includes electronic health records, operational intelligence, and workforce automation solutions that serve over 1,300 clients across the UK, Canada, and other geographies. The Company has a robust two-pronged growth strategy, targeting organic opportunities within its product suite and pursuing an aggressive M&A plan. VitalHub is headquartered in Toronto with over 700 employees globally, across key regions and the VitalHub Innovations Lab in Sri Lanka.

Read More

Analyst Recommendations for Vitalhub (TSE:VHI)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Vitalhub Right Now?

Before you consider Vitalhub, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vitalhub wasn't on the list.

While Vitalhub currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines